Healthcare Triangle is trading at $4.66, down 9.44%, with no verified company announcement clearly explaining the November 2 decline.

  • A November 2 report described an estimated $45 million business opportunity, but available reporting does not connect it to the share-price decline.
  • Broader markets were higher, not explaining the move as a same-direction market decline.
  • The latest prior-session report attributed October 30’s drop to software-sector weakness, not a confirmed November 2 catalyst.